3,066 Shares in iShares Biotechnology ETF $IBB Bought by Twin Focus Capital Partners LLC

Twin Focus Capital Partners LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,066 shares of the financial services provider’s stock, valued at approximately $443,000.

A number of other hedge funds have also recently bought and sold shares of the company. Close Asset Management Ltd raised its holdings in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after purchasing an additional 70 shares during the last quarter. Berger Financial Group Inc grew its holdings in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Berger Financial Group Inc now owns 2,829 shares of the financial services provider’s stock valued at $408,000 after acquiring an additional 75 shares in the last quarter. Kanawha Capital Management LLC boosted its position in iShares Biotechnology ETF by 0.9% in the third quarter. Kanawha Capital Management LLC now owns 8,845 shares of the financial services provider’s stock worth $1,277,000 after purchasing an additional 78 shares during the last quarter. Martin & Co. Inc. TN increased its position in shares of iShares Biotechnology ETF by 0.4% during the 2nd quarter. Martin & Co. Inc. TN now owns 20,218 shares of the financial services provider’s stock valued at $2,558,000 after purchasing an additional 79 shares during the last quarter. Finally, Choreo LLC boosted its holdings in shares of iShares Biotechnology ETF by 2.7% in the 2nd quarter. Choreo LLC now owns 3,071 shares of the financial services provider’s stock worth $389,000 after buying an additional 80 shares during the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $172.97 on Thursday. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $179.64. The company has a 50-day simple moving average of $172.85 and a 200 day simple moving average of $161.05.

iShares Biotechnology ETF Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were given a dividend of $0.1831 per share. The ex-dividend date of this dividend was Tuesday, December 16th. This represents a $0.73 dividend on an annualized basis and a dividend yield of 0.4%. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.